Choreo LLC’s Lipocine LPCN Stock Holding History

Choreo LLC’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,836	Closed	-$20.7K	–	484
2023 Q1	$20.7K	Hold	3,836	–	–	﹤0.01%	476
2022 Q4	$25K	Hold	3,836	–	–	﹤0.01%	235
2022 Q3	$29K	Hold	3,836	–	–	﹤0.01%	211
2022 Q2	$52K	Hold	3,836	–	–	﹤0.01%	214
2022 Q1	$89K	Hold	3,836	–	–	﹤0.01%	233
2021 Q4	$65K	Hold	3,836	–	–	﹤0.01%	231
2021 Q3	$71K	Hold	3,836	–	–	﹤0.01%	220
2021 Q2	$91K	Hold	3,836	–	–	﹤0.01%	219
2021 Q1	$98K	Hold	3,836	–	–	0.01%	200
2020 Q4	$89K	Hold	3,836	–	–	0.01%	200
2020 Q3	$92K	Hold	3,836	–	–	0.01%	178
2020 Q2	$82K	Hold	3,836	–	–	0.01%	180
2020 Q1	$31K	Hold	3,836	–	–	﹤0.01%	176
2019 Q4	$25K	Hold	3,836	–	–	﹤0.01%	194
2019 Q3	$183K	Buy	+3,836	New	+$154K	0.02%	185

Other funds holding LPCN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Choreo LLC's LPCN Position: Q2 2023 in Review

Choreo LLC sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 3,836 shares — an estimated $20.7K sold.

Choreo LLC first reported a position in LPCN in Q3 2019 and held it in 15 quarters. The position peaked at $183K in Q3 2019. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

Choreo LLC reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
Choreo LLC sold 3,836 Lipocine shares in Q2 2023, an estimated $20.7K.
Choreo LLC first reported a position in Lipocine in Q3 2019 and held it in 15 quarters.
Choreo LLC's Lipocine position peaked at $183K in Q3 2019.
24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on Choreo LLC's 13F filing for Q2 2023, filed 4 Aug 2023.